CAS: 252976-51-5; Ytterbium(Iii) Trifluoromethanesulfonate Xhydrate

该化合物是一种协调化合物,在+3氧化状态下,与三氟乙烷硫酸离子(三氟甲烷)及相关水分子相协调,以为成分,以为成分,通常以Yb(OTf)3nH2O为代表,其中"n"表示水分子的数量,这种成分可以变化.该化合物的特征是其杂交性质,意味着它很容易吸收环境中的湿气. Ytterbium(III)三叶酸盐经常在有机合成中用作刘易斯酸催化剂,特别是在涉及激活子体以进行进一步变异的反应中.三叶酸盐组会提高化合物在极溶剂中的溶性,使其在各种化学应用中有用.此外,丁基元素是一种稀土元素的存在有助于其独特的电子和光学特性,可以在材料科学和光学等领域加以利用.在处理这一化合物时,应当注意安全防范,因为如果在材料科学和光学中造成健康风险.

结构式图片

相似化合物

55120-76-8 128008-30-0 2926-30-9

欧盟法规

C&L通报

合成工艺路线路线简述

    专利信息


    专利号:US-2023357132-A1
    优先权日:2021-07-16
    标题:SYNTHESIS OF mRNA DELIVERY AGENT
    发明人:ZOU PING; ZUO ZHIWEI; QIU XIAOLONG; XU TAO; HU LIN; CHU LINGLING; LIU WENBO
    权利人:WISDOM PHARMACEUTICAL CO LTD
    摘要:The present disclosure relates to synthesis of an mRNA delivery agent, in particular to a reaction of a related amino compound with ethylene oxide in the presence of ytterbium triflate.

    专利号:US-10519124-B2
    优先权日:2014-04-10
    标题 :Synthesis of R-glucosides, sugar alcohols, reduced sugar alcohols, and furan derivatives of reduced sugar alcohols
    发明人:STENSRUD KENNETH; Ma chi-cheng; MARTIN KEVIN
    权利人:ARCHER DANIELS MIDLAND CO
    摘要:Disclosed herein are methods for synthesizing 1,2,5,6-hexanetetrol (HTO), 1,6 hexanediol (HDO) and other reduced polyols from C5 and C6 sugar alcohols or R glycosides. The methods include contacting the sugar alcohol or R-glycoside with a copper catalyst, most desirably a Raney copper catalyst with hydrogen for a time, temperature and pressure sufficient to form reduced polyols having 2 to 3 fewer hydoxy groups than the starting material. When the starting compound is a C6 sugar alcohol such as sorbitol or R-glycoside of a C6 sugar such as methyl glucoside, the predominant product is HTO. The same catalyst can be used to further reduce the HTO to HDO.

    专利号:US-9006231-B2
    优先权日:2008-03-03
    标 题:Cephalotaxus esters, methods of synthesis, and uses thereof
    发明人:GIN DAVID Y; WILMOT JEREMY; DJABALLAH HAKIM
    权利人:SLOAN KETTERING INST CANCER
    摘要:The present invention provides novel cephalotaxus esters, syntheses thereof, and intermediates thereto. The invention also provides pharmaceutical compositions comprising a compound of the present invention and methods of using said compounds or compositions in the treatment of proliferative diseases (e.g., benign neoplasm, cancer, inflammatory disease, autoimmune disease, diabetic retinopathy) and infectious disease. The invention further provides methods of using said compounds or compositions in the treatment of multidrug resistant cancer.

    专利号:US-2018258059-A1
    优先权日:2014-04-10
    标题:Synthesis of r-glucosides, sugar alcohols, reduced sugar alcohols, and furan derivatives of reduced sugar alcohols

    专利号:US-2017029393-A1
    优先权日:2014-04-10
    标 题 :Synthesis of r-glucosides, sugar alcohols, reduced sugar alcohols, and furan derivatives of reduced sugar alcohols

    专利号:US-2017044123-A1
    优先权日:2014-04-10
    标 题:Synthesis of r-glucosides, sugar alcohols, reduced sugar alcohols, and furan derivatives of reduced sugar alcohols

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    参考文献:10.1134/s1070428024110113
    摘要:Anwer KE, Sayed GH. Synthesis and Reactions of 2-Amino-3-Cyanopyridine Derivatives (A Review). Russ J Org Chem. 2024 Nov;60(11):2170–227. doi: 10.1134/s1070428024110113.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知